Efficacy of a broad-spectrum antibiotic (mupirocin) in an in vitro model of infected skin
- 31 October 1993
- Vol. 19 (5) , 392-395
- https://doi.org/10.1016/0305-4179(93)90059-h
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1992
- Overview of the role of mupirocinJournal of Hospital Infection, 1991
- The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectivenessJournal of Hospital Infection, 1991
- Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSAJournal of Hospital Infection, 1991
- Reduction in the colonization of central venous cannulae by mupirocinJournal of Hospital Infection, 1991
- Use of mupirocin ointment in the treatment of secondarily infected dermatosesJournal of the American Academy of Dermatology, 1990
- A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigoJournal of the American Academy of Dermatology, 1990
- Failure of mupirocin-resistant staphylococci to inactivate mupirocinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Mechanism of mupirocin transport into sensitive and resistant bacteriaAntimicrobial Agents and Chemotherapy, 1989
- An Evaluation of Topical Mupirocin in Moderately Severe Primary and Secondary Skin InfectionsJournal of International Medical Research, 1988